Corvus Pharmaceuticals Inc

NASDAQ:CRVS   2:15:51 PM EDT
4.41
-0.08 (-1.78%)
Other Pre-Announcement

Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results

Published: 03/25/2021 13:06 GMT
Corvus Pharmaceuticals Inc (CRVS) - Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results.
Corvus Pharmaceuticals Inc - Expects Full Year 2021 Net Cash Used in Operating Activities to Be Between $46 Million and $48 Million.
Corvus Pharmaceuticals Inc - As of December 31, 2020, Co Had Cash, Cash Equivalents and Marketable Securities Totaling $44.3 Million.